Neoplasma

Neoplasma

肿瘤

  • 4区 中科院分区
  • Q3 JCR分区

期刊简介

《Neoplasma》是由Vydavatel'stvo Slovenkej Akademie Vied/Veda Publishing House of the Slovak Academy of Sciences出版社于1957年创办的英文国际期刊(ISSN: 0028-2685,E-ISSN: 1338-4317),该期刊长期致力于肿瘤学领域的创新研究,主要研究方向为医学-肿瘤学。作为SCIE收录期刊(JCR分区 Q3,中科院 4区),本刊采用OA未开放获取模式(OA占比0.0040...%),以发表肿瘤学领域等方向的原创性研究为核心(研究类文章占比93.24%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在74篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Neoplasma审稿周期约为 约3月 。该刊近年未被列入国际预警名单,年发文量约74篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 74 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
4区
ONCOLOGY 肿瘤学
4区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
4区
ONCOLOGY 肿瘤学
4区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q3 221 / 322

31.5%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q3 188 / 322

41.77%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:5.4 SJR:0.588 SNIP:0.488
学科类别 分区 排名 百分位
大类:Medicine 小类:Oncology Q2 147 / 404

63%

大类:Medicine 小类:Cancer Research Q3 121 / 230

47%

期刊发文

  • LncRNA TTN-AS1 contributes to gastric cancer progression by acting as a competing endogenous RNA of miR-376b-3p.

    Author: Dong MM1, Peng SJ2, Yuan YN1, Luo HP1.

    Journal: Neoplasma. 2019 Mar 30. pii: 180927N721. doi: 10.4149/neo_2018_180927N721. [Epub ahead of print]

  • Acanthopanax senticosus polysaccharide suppressing proliferation and metastasis of the human non-small cell lung cancer NCI-H520 cells is associated with Wnt/β-catenin signaling.

    Author: Sun D1, Chen J2, Hu H3, Lin S3, Jin L1, Luo L4, Yan X3, Zhang C5.

    Journal: Neoplasma. 2019 Mar 30. pii: 180913N689. doi: 10.4149/neo_2018_180913N689. [Epub ahead of print]

  • Drug-resistance reversal in colorectal cancer cells by destruction of flotillins, the key lipid rafts proteins.

    Author: Ye DM1,2, Ye SC1, Yu SQ1,2, Shu FF1,2, Xu SS1,2, Chen QQ1,2, Wang YL2, Tang ZT2, Pan C2,1.

    Journal: Neoplasma. 2019 Mar 31;2019. pii: 180820N633. doi: 10.4149/neo_2018_180820N633.

  • LncRNA SNHG20 promotes tumorigenesis and cancer stemness in glioblastoma via activating PI3K/Akt/mTOR signaling pathway.

    Author: Gao XF1, He HQ2, Zhu XB1, Xie SL3, Cao Y4.

    Journal: Neoplasma. 2019 Mar 31;2019. pii: 180829N656. doi: 10.4149/neo_2018_180829N656.

  • The value of detecting pepsinogen and gastrin-17 levels in serum for pre-cancerous lesion screening in gastric cancer.

    Author: Yu G1, Wang GX1, Wang HG1, Mo FF1, Tang BB1.

    Journal: Neoplasma. 2019 Apr 24. pii: 180825N647. doi: 10.4149/neo_2018_180825N647. [Epub ahead of print]

  • Cucurbitacin B inhibits cell proliferation and induces cell apoptosis in colorectal cancer by modulating methylation status of BTG3.

    Author: Mao D1, Liu AH1, Wang ZP1, Zhang XW1, Lu H1.

    Journal: Neoplasma. 2019 Apr 24. pii: 180929N729. doi: 10.4149/neo_2018_180929N729. [Epub ahead of print]

  • Effects of neuroblastoma breakpoint family member 1 (NBPF1) gene on growth and Akt-p53-Cyclin D pathway in cutaneous squamous carcinoma cells.

    Author: Gao Y1, Zhu H1, Mao Q1.

    Journal: Neoplasma. 2019 Apr 24. pii: 181123N888. doi: 10.4149/neo_2018_181123N888. [Epub ahead of print]

  • Comparing the efficacy of targeted next-generation sequencing in the identification of somatic mutations in circulating tumor DNA from different stages of lung cancer.

    Author: Chen Y1, Han T2, Zhou Y1, Mao B2, Zhuang W1.

    Journal: Neoplasma. 2019 Apr 24. pii: 181130N910. doi: 10.4149/neo_2018_181130N910. [Epub ahead of print]